TOP (+)-JQ-1 ROLE IN GENE REGULATION SECRETS

Semaglutide, a glucagon like peptide-1 (GLP-1) receptor agonist, is available as monotherapy in both subcutaneous in addition to oral dosage kind (1st authorized oral GLP-1 receptor agonist). It has been accepted being a 2nd line cure choice for better glycaemic control in type two diabetes and at the moment under scrutiny for anti-weight problems